Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001140361-11-051044)

Filing Details

Accession Number:: 0001140361-11-051044
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-10-31 19:17:19
Reporting Period:: 2011-10-28

Filing Date:: 2011-10-31
Accepted Time:: 2011-10-31 19:17:19
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1048477	Biomarin Pharmaceutical Inc	BMRN	Pharmaceutical Preparations (2834)	680397820

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1221599	Steve Aselage	C/O Biomarin Pharmaceutical Inc. 105 Digital Drive Novato CA 94949	Evp, Chief Business Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-10-28	16,875	$14.39	63,353	No	4	M	Direct
Common Stock	Disposition	2011-10-28	16,875	$35.00	46,478	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2011-10-28	16,875	$0.00	16,875	$14.39

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
406,250	2009-11-12	2019-05-11	No	4	M	Direct

Footnotes

Transaction made pursuant to a Rule 10b5-1 Trading plan executed on August 25, 2011.
Original option vests 6/48ths on November 12, 2009 and 1/48th on the 12th of every month thereafter.